Mesoblast Limited
OTC: MEOBF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Silviu Itescu
- Employees
- 73
- Headquarters
- Melbourne, Australia
- IPO year
- 2010
- Market cap
- $2.0B
- Website
- https://www.mesoblast.com
Loading MEOBF…
Loading profile data…Frequently asked questions about MEOBF
What does Mesoblast Limited (MEOBF) do?
Mesoblast Limited, an Australian biopharmaceutical company established in Melbourne in 2004, specializes in the development and global commercialization of allogeneic cellular medicines. With operations spanning the United States, Australia, Singapore, the United Kingdom, and Switzerland, the firm leverages a proprietary regenerative medicine pl...
Where does MEOBF trade?
Mesoblast Limited (MEOBF) trades on the Other OTC.
What sector is MEOBF in?
Mesoblast Limited (MEOBF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Mesoblast Limited?
Silviu Itescu is the chief executive officer of Mesoblast Limited (MEOBF).
Where is Mesoblast Limited headquartered?
Mesoblast Limited is headquartered in Australia.
Does MEOBF pay a dividend?
Mesoblast Limited (MEOBF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MEOBF go public?
Mesoblast Limited (MEOBF) completed its initial public offering in 2010.